⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 15, 2024Open Access

Supplementary Data Figure S2 from KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity

Yulong Qiang Jiachen Fan Chuanshuai Xie Leilei Yan Xiaofei Song Nan Zhang Yan Lin Jie Xiong Wei Zhang Yu Liu Lei Wei Yu Li Shizhen Chen Kaiwei Liang Feng Li

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Loss of KDM5C sensitize tumor cells to BETi treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Qiang et al. (2024) studied this question.

synapsesocial.com/papers/68e6f2a2b6db64358766d23e https://doi.org/10.1158/0008-5472.25603554.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data Figure S2 from KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity2024
2Supplementary Data Figure S2 from KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity2024
3Supplementary Data Figure S2 from KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity2024
4Supplementary Data Figure S3 from KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity2024
5Supplementary Data Figure S3 from KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity2024